author-photo

S. Hominal

Metz

24

Papers

159

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

ALK-2016-CPHG: étude observationnelle prospective multicentrique en vie réelle de cancers bronchiques réarrangés ALK ou ROS1 traités par crizotinib

2021 Revue des Maladies Respiratoires Actualités
Show All
- Source
- Cite
- Save
Citations (0)
460 Spatial distribution of infiltrating T lymphocytes with Immunoscore® CR T cells exhaustion test helps stratification of NSCLC patients treated with PD1/PDL1 inhibitors in the PIONeeR project

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Prise en charge des patients atteints d’un cancer bronchopulmonaire à petites cellules de stade IV – Analyse de la base nationale de données de vie réelle du programme Épidémio-Stratégie Médico-Économique (ESME)

2021 Revue des Maladies Respiratoires Actualités
Show All
- Source
- Cite
- Save
Citations (0)
Traitements de première ligne et prise en charge du cancer broncho-pulmonaire non à petites cellules avancé ou métastatique avec une mutation EGFR–Analyse de la base nationale de données de vie réelle du programme Épidémio-stratégie médico-économique

2021 Revue des Maladies Respiratoires Actualités
Show All
- Source
- Cite
- Save
Citations (0)
Real World Data of Efficacy and Safety of Erlotinib as First-Line TKI treatment in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer: Results from the EGFR-2013-CPHG Study

2020
Show All
- Source
- Cite
- Save
Citations (0)
PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project

2020 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (4)
1310P VinMetAtezo: Phase II trial of metronomic oral vinorelbine (MOV) with atezolizumab (ATZ) for recurrent stage IV NSCLC (GFPC*04-18)**

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P1.04-30 Pioneer Study: Precision Immuno-Oncology for Advanced Non-Small Cell Lung Cancer Patients with PD1/L1 ICI Resistance

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
EP1.01-05 EGFR-2013-CPHG, a Real-World Study of EGFR Mutant Advanced Non-Small-Cell Lung Cancer Patients Treated with Erlotinib

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
125PMolecular heterogeneity assessment by NGS in non-small cell lung cancer (NSCLC) harboring EGFR mutations: Results of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France study

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (2)